Trimedyne Reports Its Financial Results for the Quarter Ended December 31, 2011
(firmenpresse) - LAKE FOREST, CA -- (Marketwire) -- 02/23/12 -- TRIMEDYNE, INC. (OTCBB: TMED) today reported its financial results for the first quarter of its fiscal year.
Revenues for the quarter ended December 31, 2011, were $1,390,000, a 15.0% decrease from revenues of $1,635,000 for the prior year's quarter. The Company had a net loss of $285,000 or $0.02 per share for the current quarter, compared to a loss of $293,000 or $0.02 per share for the same quarter of the prior year.
The current economic conditions have made business difficult for large and small companies in the medical field. As a result, we are concentrating on less developed countries in South America and Southeast Asia, where mortgage problems have not as severely impacted their economies.
Trimedyne recently introduced a line of 200, 365, 500 and 1000 micron diameter Single Use Optical Fibers for use with our Holmium Lasers, as well as Holmium Lasers with a compatible connector made by others, for the fragmentation of urinary stones in the kidney, ureter or bladder, biliary stones in the gall bladder and for other applications in surgery. Many hospitals and surgery centers want the convenience and safety of using a new optical fiber, with a factory polished tip and confirmed sterility for each case, rather than depending on their busy nurses to clean, clip and re-sterilize reusable optical fibers.
Trimedyne manufactures proprietary Holmium lasers and patented fiber optic laser devices for vaporizing the prostate to treat BPH, vaporizing spinal disc tissue to treat herniated or ruptured discs and in a variety of other, minimally invasive procedures, many of which are performed on an outpatient basis at substantially less cost than conventional surgery. For product, press release, financial, SEC Reports and other information, please visit Trimedyne's website,
"Safe Harbor" Statement Under the Private Securities Litigation Reform Act:
Statements in this news release may contain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934, including words like "expect", "may", "could" and others. Such statements may involve various risks and uncertainties, some of which may be discussed in the Company's current Form 10-K Report and subsequently filed SEC reports. There is no assurance such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements.
CONTACT:
Jeffrey Rudner
(949) 951-3800, Ext. 285
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 23.02.2012 - 14:00 Uhr
Sprache: Deutsch
News-ID 117858
Anzahl Zeichen: 0
contact information:
Town:
LAKE FOREST, CA
Kategorie:
Machinery & Tools
Diese Pressemitteilung wurde bisher 233 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Trimedyne Reports Its Financial Results for the Quarter Ended December 31, 2011"
steht unter der journalistisch-redaktionellen Verantwortung von
Trimedyne, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
